Currently holds a position at Supernus Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
Senior Vice President - Intellectual Property, Chief Scientific Officer | Supernus Pharmaceuticals Inc | March 1, 2012 - |
Vice President - Pharmaceutical Sciences | Supernus Pharmaceuticals Inc | Jan. 1, 2005 - March 1, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-25 | 2024-03-21 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
14,491
-62.8%
35.31511,677 USD |
14,491 -62.8% | 35.31 | 511,677 USD | |
2024-03-22 | 2024-03-20 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
400
-4.5%
35.3114,124 USD |
400 -4.5% | 35.31 | 14,124 USD | |
2024-03-21 | 2024-03-19 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
12,364
-59.1%
35.31436,573 USD |
12,364 -59.1% | 35.31 | 436,573 USD | |
2024-03-15 | 2024-03-13 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
36,116
-80.8%
33.481,209,164 USD |
36,116 -80.8% | 33.48 | 1,209,164 USD | |
2024-03-15 | 2024-03-13 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
26,250
-75.4%
34.10895,125 USD |
26,250 -75.4% | 34.10 | 895,125 USD | |
2024-03-14 | 2024-03-12 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
3,884
-31.2%
32.99128,133 USD |
3,884 -31.2% | 32.99 | 128,133 USD | |
2024-02-28 | 2024-02-26 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
5,000
-36.8%
30.21151,050 USD |
5,000 -36.8% | 30.21 | 151,050 USD | |
2023-01-19 | 2023-01-17 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
4,826
-74.6%
39.92192,638 USD |
4,826 -74.6% | 39.92 | 192,638 USD | |
2023-01-09 | 2023-01-06 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
174
-9.6%
39.906,943 USD |
174 -9.6% | 39.90 | 6,943 USD | |
2022-12-02 | 2022-12-01 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
5,000
-75.3%
37.48187,416 USD |
5,000 -75.3% | 37.48 | 187,416 USD | |
2022-11-15 | 2022-11-11 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
6,800
-80.5%
34.95237,655 USD |
6,800 -80.5% | 34.95 | 237,655 USD | |
2022-11-14 | 2022-11-09 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
700
-29.9%
34.9724,480 USD |
700 -29.9% | 34.97 | 24,480 USD | |
2016-04-12 | 2016-04-11 |
Supernus Pharmaceuticals Inc
(SUPN)
|
PS Planned sale |
30,762
-34.9%
16.49507,228 USD |
30,762 -34.9% | 16.49 | 507,228 USD |